gptkbp:instanceOf
|
vaccine
|
gptkbp:approvedBy
|
gptkb:FDA
|
gptkbp:ATCCode
|
gptkb:J07AL01
|
gptkbp:boosterInterval
|
at least 5 years after previous dose
|
gptkbp:brand
|
gptkb:Pneumovax_23
|
gptkbp:broadcastOn
|
single dose
|
gptkbp:contraindication
|
severe allergic reaction to vaccine component
|
gptkbp:fullName
|
Pneumococcal Polysaccharide Vaccine 23-valent
|
https://www.w3.org/2000/01/rdf-schema#label
|
PPSV23
|
gptkbp:manufacturer
|
gptkb:Merck_&_Co.
|
gptkbp:notRecommendedFor
|
children under 2 years
|
gptkbp:numberOfSerotypes
|
23
|
gptkbp:protectedBy
|
gptkb:Streptococcus_pneumoniae
|
gptkbp:recommendation
|
immunocompromised individuals
adults 65 years and older
people with certain chronic medical conditions
|
gptkbp:routeOfAdministration
|
intramuscular
subcutaneous
|
gptkbp:sideEffect
|
fever
injection site reaction
muscle aches
|
gptkbp:usedFor
|
prevention of invasive pneumococcal disease
prevention of pneumococcal disease
prevention of pneumonia
|
gptkbp:WHOStatus
|
gptkb:WHO_Model_List_of_Essential_Medicines
|
gptkbp:bfsParent
|
gptkb:PCV20
|
gptkbp:bfsLayer
|
5
|